Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

218 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
Ettinger DS, Berkey BA, Abrams RA, Fontanesi J, Machtay M, Duncan PJ, Curran WJ Jr, Movsas B, Byhardt RW; Radiation Therapy Oncology Group 9609. Ettinger DS, et al. Among authors: machtay m. J Clin Oncol. 2005 Aug 1;23(22):4991-8. doi: 10.1200/JCO.2005.00.414. Epub 2005 Jun 6. J Clin Oncol. 2005. PMID: 15939930 Clinical Trial.
Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced squamous cell carcinoma of the head and neck.
Rosenthal DI, Lee JH, Sinard R, Yardley DA, Machtay M, Rosen DM, Egorin MJ, Weber RS, Weinstein GS, Chalian AA, Miller LK, Frenkel EP, Carbone DP. Rosenthal DI, et al. Among authors: machtay m. J Clin Oncol. 2001 Mar 1;19(5):1363-73. doi: 10.1200/JCO.2001.19.5.1363. J Clin Oncol. 2001. PMID: 11230480 Clinical Trial.
A phase III comparison of radiation therapy with or without recombinant beta-interferon for poor-risk patients with locally advanced non-small-cell lung cancer (RTOG 93-04).
Bradley JD, Scott CB, Paris KJ, Demas WF, Machtay M, Komaki R, Movsas B, Rubin P, Sause WT. Bradley JD, et al. Among authors: machtay m. Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1173-9. doi: 10.1016/s0360-3016(01)02797-3. Int J Radiat Oncol Biol Phys. 2002. PMID: 11955727 Clinical Trial.
Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania Phase II Trial.
Machtay M, Rosenthal DI, Hershock D, Jones H, Williamson S, Greenberg MJ, Weinstein GS, Aviles VM, Chalian AA, Weber RS; Penn Cancer Center Clinical Trials Group. Machtay M, et al. J Clin Oncol. 2002 Oct 1;20(19):3964-71. doi: 10.1200/JCO.2002.11.026. J Clin Oncol. 2002. PMID: 12351593 Clinical Trial.
218 results